Urology Companies in BioPortfolio's Corporate Database - Page: 4
Urology company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Urology companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Urology Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Urology Companies.
More Information about Urology on BioPortfolio
We have published hundreds of Urology news stories on BioPortfolio along with dozens of Urology Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Urology for you to read.
Showing "urology kidneys ureters bladder prostate" Companies 76 to 100 of 237
Vaxon Biotech, founded in early 2004 and based in Evry Genopole - France, is a product-driven biopharmaceutical company focusing on the discovery and development of innovative vaccines for the treatment of malignancies, including prostate, lung, breast and colon cancer. The company is based on an original discovery made by Dr. Kostas Kosmatopoulos and his team: optimized cryptic peptides. Vaxon Bi...
Viventia Biotech Inc. is a biopharmaceutical company advancing a new generation of monoclonal antibody therapeutics designed to offer safer, more beneficial therapies for cancer patients. Viventia’s lead product candidate Proxinium™ continues on an aggressive clinical development schedule. Viventia has initiated a Phase II North American clinical trial and concurrently commenced a pivotal Phas...
YM BioSciences is a product development company. Our focus is to advance cancer products along the regulatory and clinical pathways towards commercial approval. YMB does not conduct basic research; rather, our product portfolio is established through a process of careful, rational selection of therapeutics produced in research institutions around the globe. We have one of the broadest oncology po...
Dean Janes founded the Company as Imaging Services, Inc. on October 29, 1993. In order to better position the Company for its future direction -- away from service and towards providing proprietary medical imaging products -- the Company changed its name from Imaging Services, Inc. to Imaging3, Inc. on August 20, 2002. While the Company began as a service provider, it quickly expanded to include...
Orthotopix is a preclinical contract research company specialized in cell, tissue and animal models modeling the prevention and treatment of breast and prostate cancer. Our products also include an unique urodynamical model of urethal function and a cell line based safety model of uterus. All these are offered as a tailored service for drug development and pharma companies.
Anavex Life Sciences Corp. ( www.anavex.com ) is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR(TM) Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances....
iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography and comp...
Ed Randall's Fans For The Cure was founded in 2002 after the charityâs founder, Ed Randall, was diagnosed with prostate cancer. After treatment at St. Lukeâs-Roosevelt Hospital, Ed's cancer went into, and remains, in remission. Ed Randall is the host of Ed Randallâs Talking Baseball on Sirius/XM Radio Channel 175 and WFAN Radio in New York. Heâ...
This combines three automated blood tests into one index that estimates a man's probability of having prostate cancer found on biopsy. Beckman Coulter phi is a composite score of Access Hybritech PSA, free PSA and the new p2PSA (not available in the United States) assay, which measures the free PSA isoform [-2]proPSA. This assessment can only be carried out in a hospital or medically approved...
Prostate Oncology Specialists, Inc.
According to the American Cancer Society, prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than two million men in the United States have prostate cancer, with an estimated 217,730 new cases and approximately 32,050 men expected to die from the disease in 2010.
Kanzius Cancer Research Foundation
The Kanzius Cancer Research Foundation is a 501(c)(3) non-profit organization with a mission to create national and global awareness of the potentials of the Kanzius Noninvasive Radiowave Cancer Treatment, and to help accelerate the speed at which this research progresses to human trials. The goal of KCRF is to raise money to support ongoing research grants. Pancreatic, liver and colorectal cance...
Headquartered in La Jolla, California, DermTech is focused on the development of the company's patented Epidermal Genetic Information Retrieval (EGIR(TM)) technology. The EGIR technology uses a custom adhesive tape to non-invasively and easily collect cells from the stratum corneum, i.e., the upper layer of the skin. Genetic material (RNA) from these cells is then isolated, amplified and analyze...
MabCure is a biotechnology company whose vision is to change the perception of cancer as being a largely incurable disease. MabCure owns proprietary technology for the creation of unique and highly specific monoclonal antibodies (MAbs), which we plan to develop as diagnostic tools, imaging agents, and drugs to treat lethal cancers. MabCureâs initial g...
MyoPowers Medical Technologies SA
MyoPowers Medical Technologies, formerly known as Nanopowers, was founded by Dr Piergiorgio Tozzi of the University Hospital of Lausanne (CHUV) and Professor Daniel Hayoz of the Cantonal Hospital of Fribourg and the CHUV. In 2009, the company was selected as one of the best innovative medical technology companies by the Swiss Commission for Technology and...
Precision Biopsy, LLC is a privately-held startup company formed by Allied Minds, Inc. in cooperation with the University of Colorado to commercialize a revolutionary optical biopsy technology designed to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer. www.precisionbiopsy.com
Solutions for Intimacy is a comprehensive program providing couples with the tools, resources and knowledge to live a sexually fulfilling life after prostate cancer. It was founded in 2011 by husband-and-wife-team Steve Frohman and Cindie Hubiak, following Frohmanâs battle with the disease. For more information, visit www.solutionsforintimacy.com.
Heat Biologics (www.heatbio.com) (âHeatâ) is a clinical-stage company immunotherapy company focused on developing its novel off-the-shelf âImPACTâ (Immune Pan-Antigen Cytotoxic Therapy) therapeutic vaccines to combat a wide range of cancers and other diseases. Heatâs ImPACT Therapy effectively reprograms tumor cells to âpump o...
Texas Oncology delivers high-quality cancer care with leading-edge technology and advanced treatment and therapy options available to help patients achieve âMore breakthroughs. More victories.â® in their fights against cancer. Texas Oncology, a pioneer in community-based cancer care, is an independent oncology practice with sites of service th...
Cold Genesys Incorporated is a privately held biopharmaceutical company that is focused on delivering innovative conditionally replicative (Rb pathway defective molecule E2F as the viral E1A gene promoter) competent oncolytic adenovirus vector expressing GM-CSF for the treatment of patients with bladder cancer. CGI acquired the intellectual property...
Addex Therapeutics is pioneering discovery and development of an emerging class of oral small molecule drugs, called allosteric modulators, which can be exquisitely selective for their intended target and confer significant therapeutic advantages over conventional “orthosteric” small molecule or biological drugs. The Company uses its proprietary discovery platform to address receptor...
Calypso Medical Technologies, Inc.
Calypso Medical Technologies, Inc. is a Seattle-based, privately held medical device company. The Companyâs proprietary tumor localization system utilizes miniaturized implanted devices (Beacon electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therap...
Aduro BioTech is a clinical-stage immunotherapy company developing novel and potent vaccines based on Listeria monocytogenes. The company has engineered two distinct Listeria vaccine platforms to be safe for use in humans while continuing to induce robust immune responses. These advances have been published in 20 major studies and have generated more than...
AmpliMed Corporation develops novel drugs for the treatment of cancer. Our lead product, Amplimexon™ (imexon inj.), has particular promise for the treatment of pancreatic cancer, malignant melanoma, lung cancer and multiple myeloma. Other products in our portfolio have promise in ovarian, breast, prostate and other common cancers. Our compounds have novel ways of killing cancer cells which are d...
Through the Power of Our People, and in accordance with the AdvaMed Code of Ethics, we continue to develop new therapies to restore bodily functions and to enable people to regain control of their lives. These therapies are often inspired by the urologists, gynecologists and urogynecologists who choose AMS as their solutions partner ... truly the Surgeon's Choice. Several of our treatments are so...
At ImaRx, our goal is to improve patient outcomes by restoring critical bloodflow to organs such as the brain, heart, and lungs following acute ischemic or thrombotic events through our innovative technology and products.We are pursuing two development programs as the foundation for our products. The first program is a group of clot-dissolving drugs, or thrombolytics, that are variants of urokinas...
